| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | Chief Operating Officer | Svp--product Development
2 companies
Krishnan Suma is a President, R&D at Krystal Biotech, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 34 sells.
Estimated insider holdings value: $489.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Sell | 100,000 | $70.50 | $7,050,000.00 | -66.7% | -7.7% | -0.7% | |
| Sep 17, 2020 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Sell | 50,000 | $46.37 | $2,318,629.20 | -0.4% | - | - | |
| Jun 15, 2020 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Sell | 50,000 | $43.50 | $2,174,774.96 | -0.5% | - | - | |
| Mar 18, 2020 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Sell | 15,398 | $40.49 | $623,411.71 | -0.2% | - | - | |
| Dec 18, 2019 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Sell | 50,000 | $62.04 | $3,101,953.96 | -0.2% | - | - | |
| Oct 18, 2018 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Buy | 25,000 | $20.00 | $500,000.00 | +1.3% | - | - | |
| Jun 6, 2018 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Buy | 25,000 | $11.02 | $275,609.26 | +0.4% | - | - | |
| Sep 22, 2017 | KRYS Krystal Biotech, Inc. | Chief Operating Officer | Buy | 100,000 | $10.00 | $1,000,000.00 | +5.4% | - | - | |
| Dec 4, 2015 | PGEN Precigen, Inc. | Svp--product Development | Sell | 20,900 | $35.66 | $745,370.97 | -19.8% | - | - |